Improved survival after multimodal approach with 131I treatment in patients with bone metastasis secondary to differentiated thyroid cancer.

CONCLUSIONS: In patients with differentiated thyroid cancer with bony metastases, 131I treatment in combination with one or more non-131I direct and systemic treatments had a significant increase in overall survival compared with those patients who were treated by 131I treatment alone. PMID: 31017051 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research